HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Scott D Lick Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lick, S. D. Search for Related Content PubMed Articles by Lick, S. D.

Ann Thorac Surg 2001;71:1756
© 2001 The Society of Thoracic Surgeons

---

Correspondence

Controlled perfusion of the transplanted lung: Reply

^a Department of Cardiothoracic Surgery, University of Texas Medical Branch, 301 University Blvd, Route 0528, Galveston, TX 77555-0528, USA

(Email: slick@utmb.edu).

The first 20% of the full text of this article appears below.

To the Editor

Given Dr Clark’s premises, Occam’s (therapeutic) razor favors pentoxifylline. The notion that a single injection of a drug—and one so common and safe as pentoxifylline (better known in its oral form as a rheologic "lubricant" for red blood cells in claudicators)—will ameliorate lung injury is enticing.

However, upon revisiting Dr Clark’s group’s papers, controlled reperfusion did not get its fair due. In their model of controlled reperfusion [1], . . . [Full Text of this Article]

This article has been cited by other articles:

				N. Sawabata, A. Matsumura, A. Motohiro, Y. Osaka, K. Gennga, S. Fukai, and T. Mori Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis? Ann. Thorac. Surg., February 1, 2002; 73(2): 412 - 415. [Abstract] [Full Text] [PDF]